본문 바로가기
KERD
논문KCI 등재

당뇨족으로 인한 비외상성 하퇴부 절단 환자에서 시행한 절단부 창상의 치 유 기간과 Ischemia-Modified Albumin과의 관계

Relationship between Ischemia–Modified Albumin and the Healing Period of Amputation Wounds in Patients with Diabetes Mellitus Following Non-traumatic Below-Knee Amputation

이명진|김현준|허시영|변성빈
대한족부족관절학회 (korean foot and ankle society)|2023.06|대한족부족관절학회지 (journal of korean foot and ankle society)|제27권 제2호|pp. 49-54|DOI 10.14193/jkfas.2023.27.2.49

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

Wound healingDiabetic footFoot ulcerAmputationIschemia-modified albumin

초록

Purpose: The present study examined the effectiveness of the preoperative ischemia-modified albumin (IMA) levels in predicting the healing period of amputation wounds in patients with diabetes mellitus following a non-traumatic below-knee amputation (BKA). Materials and Methods: This study enrolled 41 diabetic foot ulcer patients who underwent BKA at the authors’ hospital diabetic foot center from April 2016 to April 2022. Among the 41 patients, 29 (70.7%) were male and 12 (29.3%) were female. Their mean age was 64.54±11.38 years (41~81 years). The mean follow-up period was 19.48±5.56 weeks (14~48 weeks) after BKA. The patients were divided into two groups (high IMA group and normal IMA group), which evaluated the healing period, wound dehiscence, and revision opera- tion rate using a Fisher's exact test and Mann–Whitney U test. Three orthopedic surgeons performed stump wound evaluation, and they were evaluated as healing when all sutures were fused without oozing. Results: Thirty patients (73.2%) (group A) showed a high level of IMA (median: 91.2 U/mL), and 11 (26.8%) patients (group B) showed a normal range of IMA (median: 82.7 U/mL). In group A, the median period for wound healing took 1.4 weeks longer, which was sig- nificant (p=0.001). No statistical relationship was observed between wound dehiscence, revision operation rate, and IMA value. There was no correlation between the other risk factors (estimated glomerular filtration rate, HbA1c) and the wound healing period. Conclusion: Although there was a limitation in using IMA as the sole factor to predict the healing period of amputation wounds in patients after BKA, this study revealed a significant positive correlation between IMA and the period of stump healing after BKA. There- fore, the preoperative IMA levels may help predict the period of stump healing after BKA

Abstract

Purpose: The present study examined the effectiveness of the preoperative ischemia-modified albumin (IMA) levels in predicting the healing period of amputation wounds in patients with diabetes mellitus following a non-traumatic below-knee amputation (BKA). Materials and Methods: This study enrolled 41 diabetic foot ulcer patients who underwent BKA at the authors’ hospital diabetic foot center from April 2016 to April 2022. Among the 41 patients, 29 (70.7%) were male and 12 (29.3%) were female. Their mean age was 64.54±11.38 years (41~81 years). The mean follow-up period was 19.48±5.56 weeks (14~48 weeks) after BKA. The patients were divided into two groups (high IMA group and normal IMA group), which evaluated the healing period, wound dehiscence, and revision opera- tion rate using a Fisher's exact test and Mann–Whitney U test. Three orthopedic surgeons performed stump wound evaluation, and they were evaluated as healing when all sutures were fused without oozing. Results: Thirty patients (73.2%) (group A) showed a high level of IMA (median: 91.2 U/mL), and 11 (26.8%) patients (group B) showed a normal range of IMA (median: 82.7 U/mL). In group A, the median period for wound healing took 1.4 weeks longer, which was sig- nificant (p=0.001). No statistical relationship was observed between wound dehiscence, revision operation rate, and IMA value. There was no correlation between the other risk factors (estimated glomerular filtration rate, HbA1c) and the wound healing period. Conclusion: Although there was a limitation in using IMA as the sole factor to predict the healing period of amputation wounds in patients after BKA, this study revealed a significant positive correlation between IMA and the period of stump healing after BKA. There- fore, the preoperative IMA levels may help predict the period of stump healing after BKA

참고문헌 (25)

  1. Andrew J.M. Boulton, "The Pathway to Foot Ulceration in Diabetes", Medical Clinics of North America, 97(5), pp.775~790 (2013), Elsevier BV[DOI]
  2. Edward W. Gregg, "Prevalence of lower-extremity disease in the US adult population ≥40years of age with and without diabetes: 1999-2000 national health and nutrition examination survey", Diabetes Care, 27(7), pp.1591~1597 (2004), American Diabetes Association[DOI]
  3. Harry B. Kram, "Prediction of below-knee amputation wound healing using noninvasive laser Doppler velocimetry", The American Journal of Surgery, 158(1), pp.29~31 (1989), Elsevier BV[DOI]
  4. D A Ratliff, "Prediction of amputation wound healing: The role of transcutaneous pO2 assessment", British Journal of Surgery, 71(3), pp.219~222 (1984), Oxford University Press (OUP)[DOI]
  5. Gayle E. Reiber, "Risk factors for amputation in patients with diabetes mellitus. A case-control study", Annals of Internal Medicine, 117(2), pp.97~105 (1992), American College of Physicians[DOI]
  6. Zhen-Yu Zhou, "HbA1c and lower extremity amputation risk in patients with diabetes: a metaanalysis", The International Journal of Lower Extremity Wounds, 14(2), pp.168~177 (2015), SAGE Publications[DOI]
  7. Wenhui Zhao, "HbA1c and Lower-Extremity Amputation Risk in Low-Income Patients With Diabetes", Diabetes Care, 36(11), pp.3591~3598 (2013), American Diabetes Association[DOI]
  8. Kunihiro Matsushita, "Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data", Lancet Diabetes Endocrinol, 5(9), pp.718~728 (2017), Elsevier BV[DOI]
  9. Kurniawati A, "Prognostic factors for lower extremity amputation in diabetic foot ulcer patients", J Acute Med, 9, pp.59~63 (2019)[DOI]
  10. Alla Shevtsova, "Ischemia-Modified Albumin: Origins and Clinical Implications", Disease Markers, 2021, pp.1~18 (2021), Hindawi Limited[DOI]
  11. Manas K. Sinha, "Ischemia Modified Albumin Is a Sensitive Marker of Myocardial Ischemia After Percutaneous Coronary Intervention", Circulation, 107(19), pp.2403~2405 (2003), Ovid Technologies (Wolters Kluwer Health)[DOI]
  12. Jason H. Calhoun, "Treatment of diabetic foot infections: Wagner classification, therapy, and outcome", Foot Ankle, 9(3), pp.101~106 (1988), SAGE Publications[DOI]
  13. Sbarouni E, "Ischemia modified albumin : is this marker of ischemia ready for prime time use?", Hellenic J Cardiol, 49, pp.260~266 (2008)
  14. F. S. Apple, "Future Biomarkers for Detection of Ischemia and Risk Stratification in Acute Coronary Syndrome", Clinical Chemistry, 51(5), pp.810~824 (2005), Oxford University Press (OUP)[DOI]
  15. EMMANUEL BOURDON, "Glucose and free radicals impair the antioxidant properties of serum albumin", The FASEB Journal, 13(2), pp.233~244 (1999), Wiley[DOI]
  16. Bernard Chan, "Site‐specific N‐terminal Auto‐degradation of Human Serum Albumin", European Journal of Biochemistry, 227(1-2), pp.524~528 (1995), Wiley[DOI]
  17. Ma SG, "Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease", Clinics(Sao Paulo), 66, pp.1677~1680 (2011)[DOI]
  18. Dane K. Wukich, "Comparison of Transtibial Amputations in Diabetic Patients With and Without End-Stage Renal Disease", Foot Ankle Int, 38(4), pp.388~396 (2017), SAGE Publications[DOI]
  19. Jason Pollard, "Mortality and Morbidity After Transmetatarsal Amputation: Retrospective Review of 101 Cases", The Journal of Foot and Ankle Surgery, 45(2), pp.91~97 (2006), Elsevier BV[DOI]
  20. Jing Chen, "Risk Factors for Peripheral Arterial Disease Among Patients With Chronic Kidney Disease", The American Journal of Cardiology, 110(1), pp.136~141 (2012), Elsevier BV[DOI]
  21. Evangelia Dounousi, "Oxidative Stress Is Progressively Enhanced With Advancing Stages of CKD", American Journal of Kidney Diseases, 48(5), pp.752~760 (2006), Elsevier BV[DOI]
  22. Robin J. Ruthenborg, "Regulation of Wound Healing and Fibrosis by Hypoxia and Hypoxia-Inducible Factor-1", Molecules and Cells, 37(9), pp.637~643 (2014), 한국분자세포생물학회[DOI]
  23. Majed A. Refaai, "Ischemia-modified albumin increases after skeletal muscle ischemia during arthroscopic knee surgery", Clinica Chimica Acta, 366(1-2), pp.264~268 (2006), Elsevier BV[DOI]
  24. Edgar Zapico-Muñiz, "Ischemia-Modified Albumin during Skeletal Muscle Ischemia", Clinical Chemistry, 50(6), pp.1063~1065 (2004), Oxford University Press (OUP)[DOI]
  25. Dong-Hyeon Lee, "Change in Ischemia-Modified Albumin and Its Clinical Significance During Exercise Stress Testing", Circulation Journal, 74(3), pp.484~489 (2010), Japanese Circulation Society[DOI]

관련 논문AI추천

당뇨 합병증으로 인한 하지 절단술의 위험 인자의 포괄적 분석감민철, 민병권, 박재구, 배서영, 정형진, 최지원대한족부족관절학회 · 대한족부족관절학회지2012 · 제16권 제4호당뇨발 환자에서 Syme 절단술의 위험 인자곽희철, 김영준, 김전교, 이운성, 이정한대한족부족관절학회 · 대한족부족관절학회지2016 · 제20권 제2호단일 족지 절단 환자의 상처 치유 위험인자에 대한 통계적 분석배서영, 신우진, 이준호, 정형진대한족부족관절학회 · 대한족부족관절학회지2019 · 제23권 제1호당뇨족 환자에서 동측 족부 및 하지 재절단술의 발생빈도 및 위험인자김명수, 박형택, 이창범, 최선진, 하정한대한족부족관절학회 · 대한족부족관절학회지2011 · 제15권 제1호당뇨병성 족부 궤양에 의한 절단술후 상처 치유와 발목-상완 지수, 족지-상완 지수, 족지압의 관계김유진, 박세진, 이재욱, 정화재대한족부족관절학회 · 대한족부족관절학회지2012 · 제16권 제4호Risk factors affecting amputation in diabetic footHyoung Woo Lee, Ji Sung Yoon, Jun Ho Lee, Jun Sung Moon, Kyu Chang Won, Seung Min Chung, Yin Young Lee영남대학교 의과대학 · Journal of Yeungnam Medical Science2020 · 제37권 제4호

이 간행물의 다른 논문 (7건)

아킬레스건 소매 견열이우승, 여의동, 정진욱, 민병권pp. 39-42골다공증성 족관절 골절이효범, 김갑래, 김철현pp. 43-48전경골건 파열의 임상 양상전현식, 정재중, 박상은pp. 55-57Effect of Deltoid Ligament Repair on Syndesmotic Stabilization in Patients with Ankle Fractures최홍준, 김대욱pp. 58-66COVID-19 백신 접종 후 발생한 다발성 농양 1예: 증례 보고김태호, 김갑래, 이효범pp. 67-70
원문 보기